Complete disappearance of pulmonary metastases in a case of hepatocellular carcinoma treated with docetaxel-based systemic chemotherapy

被引:10
作者
Ishikawa, T
Ichida, T
Yokoyama, J
Matsuda, Y
Watanabe, T
Asakura, H
机构
[1] Niigata Univ, Sch Med, Dept Internal Med 3, Niigata 9518122, Japan
[2] Saiseikai Sanjo Hosp, Div Gastroenterol & Hepatol, Niigata, Japan
关键词
docetaxel; hepatocellular carcinoma; lung metastasis;
D O I
10.1111/j.1440-1746.2004.03737.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A case of the complete shrinkage of pulmonary metastases from multiple hepatocellular carcinomas (HCC) after administration of docetaxel, cisplatin and enteric-coated tegafur/uracil is reported. A 54-year-old Japanese man was diagnosed with recurrent multiple HCC associated with pulmonary metastases and compensated liver cirrhosis. Docetaxel, cisplatin and enteric-coated tegafur/uracil were given to this patient. After 2 months of treatment, there was a decrease in tumor markers and a shrinkage of the pulmonary metastases. Image analyses such as chest X-rays and chest computed tomography scans showed a disappearance of the pulmonary metastases, although the multiple HCC did not disappear completely. This was evaluated as a complete remission of metastatic lesions or a partial remission of primary lesions according to the World Health Organization criteria. No recurrence of pulmonary metastasis was seen for 10 months. This combination therapy was well-tolerated for lung cancer and could represent an effective treatment for pulmonary metastases from HCC. (C) 2004 Blackwell Publishing Asia Pty Ltd.
引用
收藏
页码:1423 / 1426
页数:4
相关论文
共 22 条
[11]  
Löffler TM, 1998, SEMIN ONCOL, V25, P32
[12]  
MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO
[13]  
2-6
[14]   Spontaneous regression of hepatocellular carcinoma [J].
Okada, S ;
Abo, T .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (09) :965-966
[15]   THE TAXOIDS - PACLITAXEL (TAXOL(R)) AND DOCETAXEL (TAXOTERE(R)) [J].
PAZDUR, R ;
KUDELKA, AP ;
KAVANAGH, JJ ;
COHEN, PR ;
RABER, MN .
CANCER TREATMENT REVIEWS, 1993, 19 (04) :351-386
[16]   TRANSECTION OF ESOPHAGUS FOR BLEEDING ESOPHAGEAL VARICES [J].
PUGH, RNH ;
MURRAYLY.IM ;
DAWSON, JL ;
PIETRONI, MC ;
WILLIAMS, R .
BRITISH JOURNAL OF SURGERY, 1973, 60 (08) :646-649
[17]   Docetaxel delivers new management opportunities for gastrointestinal carcinomas [J].
Rougier, P .
ANTI-CANCER DRUGS, 1995, 6 :25-29
[18]   COPING WITH TOXICITIES OF DOCETAXEL (TAXOTERE(TM)) [J].
SCHRIJVERS, D ;
WANDERS, J ;
DIRIX, L ;
PROVE, A ;
VONCK, I ;
VANOOSTEROM, A ;
KAYE, S .
ANNALS OF ONCOLOGY, 1993, 4 (07) :610-611
[19]   Phase I study of a weekly 1 h infusion of paclitaxel in patients with unresectable hepatocellular carcinoma [J].
Strumberg, D ;
Erhard, J ;
Harstrick, A ;
Klaassen, U ;
Muller, C ;
Eberhardt, W ;
Wilke, H ;
Seeber, S .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (08) :1290-1292
[20]  
TAKAHASHI Y, 1995, J NATL CANCER I, V87, P1262